Novartis Inc header image

Novartis Inc

NVS

Equity

ISIN US66987V1098 / Valor 567514

New York Stock Exchange, Inc (2024-11-20)
USD 103.09-0.17%

Novartis Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Novartis Inc is a global pharmaceutical company known for its innovative medicines that aim to improve and extend people's lives. The company's Executive Committee oversees its business operations, which reach over 250 million people worldwide. Novartis focuses on reimagining medicine to empower patients, healthcare professionals, and societies in the fight against serious diseases.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Q2 2024 Net Sales

In Q2 2024, Novartis Inc reported net sales of USD 12,512 million, reflecting a 9% increase compared to Q2 2023. When adjusted for constant currencies, the growth rate was 11%.

Q2 2024 Operating Income

Novartis Inc's operating income for Q2 2024 was USD 4,014 million, a significant 43% increase from the USD 2,807 million reported in Q2 2023. On a constant currency basis, the growth was 47%.

Q2 2024 Net Income

For Q2 2024, Novartis Inc achieved a net income of USD 3,246 million, marking a 43% rise from the USD 2,271 million recorded in Q2 2023. The constant currency growth rate was 49%.

Q2 2024 Earnings Per Share (EPS)

Novartis Inc's earnings per share (EPS) for Q2 2024 stood at USD 1.60, up 47% from USD 1.09 in Q2 2023. When adjusted for constant currencies, the EPS growth was 52%.

Q2 2024 Free Cash Flow

In Q2 2024, Novartis Inc generated a free cash flow of USD 4,615 million, representing a 40% increase compared to the USD 3,292 million reported in Q2 2023.

Summarized from source with an LLMView Source

Key figures

8.23%1Y
26.2%3Y
13.9%5Y

Performance

16.9%1Y
18.5%3Y
20.6%5Y

Volatility

Market cap

214789 M

Market cap (USD)

Daily traded volume (Shares)

216,530

Daily traded volume (Shares)

1 day high/low

103.18 / 102.47

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.72%EUR 41.80
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 4.18
MPH Health Care AG
MPH Health Care AG MPH Health Care AG Valor: 57233620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%EUR 25.00
aap Implantate AG
aap Implantate AG aap Implantate AG Valor: 57872565
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.00%EUR 2.02
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203211
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%CHF 264.40
Arjo AB
Arjo AB Arjo AB Valor: 39115843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%SEK 33.02
Oncopeptides AB
Oncopeptides AB Oncopeptides AB Valor: 35671972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.48%SEK 1.49
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.85%USD 37.48
Sienna Senior Living Inc
Sienna Senior Living Inc Sienna Senior Living Inc Valor: 28093100
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.01%CAD 16.99
WELL Health Technologies Corp
WELL Health Technologies Corp WELL Health Technologies Corp Valor: 42769021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.19%CAD 5.14